1. Home
  2. SHIM vs ACRV Comparison

SHIM vs ACRV Comparison

Compare SHIM & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$3.14

Market Cap

97.5M

Sector

N/A

ML Signal

HOLD

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$2.40

Market Cap

82.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIM
ACRV
Founded
1990
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.5M
82.7M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
SHIM
ACRV
Price
$3.14
$2.40
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$14.67
AVG Volume (30 Days)
37.3K
449.4K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$495,984,000.00
N/A
Revenue This Year
$6.91
N/A
Revenue Next Year
$13.03
$805.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$1.05
52 Week High
$3.50
$8.00

Technical Indicators

Market Signals
Indicator
SHIM
ACRV
Relative Strength Index (RSI) 68.37 52.45
Support Level $2.60 $2.12
Resistance Level $2.98 $2.44
Average True Range (ATR) 0.20 0.20
MACD 0.04 -0.02
Stochastic Oscillator 78.41 44.26

Price Performance

Historical Comparison
SHIM
ACRV

About SHIM Shimmick Corporation

Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Share on Social Networks: